# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA858715 | F | Inhibition of drug-sensitive Plasmodium falciparum 3D7 after 72 hrs | Plasmodium falciparum | 27 | ALA1141868 | organism-based format | Scientific Literature | |
2. | ALA858716 | F | Inhibition of drug-resistant Plasmodium falciparum Dd2 after 72 hrs | Plasmodium falciparum | 27 | ALA1141868 | organism-based format | Scientific Literature | |
3. | ALA858717 | B | Inhibition of PfENR enzymatic activity | Plasmodium falciparum | 27 | ALA1141868 | single protein format | Scientific Literature | |
4. | ALA1246344 | A | Metabolic stability in human liver microsome assessed as compound remaining after 60 mins | Homo sapiens | 2 | ALA1240506 | microsome format | Scientific Literature | |
5. | ALA1246345 | B | Inhibition of Toxoplasma gondii enoyl reductase | Toxoplasma gondii | 25 | ALA1240506 | single protein format | Scientific Literature | |
6. | ALA1246346 | F | Antiparasitic activity against Toxoplasma gondii infected in HFF after 24 hrs by [3H]uracil incorporation assay | Toxoplasma gondii | 54 | ALA1240506 | organism-based format | Scientific Literature | |
7. | ALA1246347 | T | Toxicity to HFF | Homo sapiens | 40 | ALA1240506 | cell-based format | Scientific Literature | |
8. | ALA1246348 | F | Antiparasitic activity against Toxoplasma gondii RH infected in ip dosed CD1 mouse | Toxoplasma gondii | 2 | ALA1240506 | organism-based format | Scientific Literature | |
9. | ALA1246349 | A | Inhibition of CYP2C9 at 10 uM | 2 | ALA1240506 | single protein format | Scientific Literature | ||
10. | ALA1246350 | A | Inhibition of CYP2D6 at 10 uM | 2 | ALA1240506 | single protein format | Scientific Literature | ||
11. | ALA1246351 | A | Inhibition of CYP3A4 at 10 uM | 2 | ALA1240506 | single protein format | Scientific Literature | ||
12. | ALA1246352 | T | Toxicity to HFF at highest concentration | Homo sapiens | 42 | ALA1240506 | cell-based format | Scientific Literature | |
13. | ALA5231312 | B | Inhibition of Bacillus anthracis enoyl ACP reductase assessed as inhibition of bacterial growth | Bacillus anthracis | 2 | ALA5230110 | assay format | Scientific Literature | |
14. | ALA5231313 | F | Antibacterial activity against Bacillus anthracis assessed as reduction in bacterial growth measured after 24 hrs by broth microdilution method | Bacillus anthracis | 2 | ALA5230110 | organism-based format | Scientific Literature | |
15. | ALA5231318 | F | Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as reduction in bacterial growth incubated for 12 hrs by microdilution method | Staphylococcus aureus | 4 | ALA5230110 | organism-based format | Scientific Literature | |
16. | ALA5231319 | F | Bactericidal activity against methicillin-resistant Staphylococcus aureus measured after 24 hrs by sub-culturing | Staphylococcus aureus | 2 | ALA5230110 | organism-based format | Scientific Literature | |
17. | ALA5231320 | F | Antibacterial activity against methicillin-sensitive Staphylococcus aureus assessed as reduction in bacterial growth incubated for 12 hrs by microdilution method | Staphylococcus aureus | 2 | ALA5230110 | organism-based format | Scientific Literature | |
18. | ALA5231322 | F | Cytotoxicity against human HeLa cells assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay | Homo sapiens | 2 | ALA5230110 | cell-based format | Scientific Literature | |
19. | ALA5231323 | F | Cytotoxicity against mouse MH-S cells | Mus musculus | 2 | ALA5230110 | cell-based format | Scientific Literature | |
20. | ALA5232762 | B | Inhibition of Toxoplasma gondii recombinant ENR in presence of NADH by absorbance based analysis | Toxoplasma gondii | 11 | ALA5230160 | assay format | Scientific Literature |